Beam Therapeutics (BEAM) Competitor Comparison
We are evaluating the key criteria listed to compare Beam Therapeutics (BEAM) against its competitors in the Biotechnology industry.
Market Capitalization
51 / 368Gross Profits
267 / 278Total Revenue
98 / 300EBITDA
315 / 337Free Cashflow
328 / 352Quick Ratio
196 / 357Earnings per Share
181 / 359Dividend yield
0 / 6Total Cash
23 / 358Performance 3 years
204 / 368Performance 5 years
126 / 368Performance 10 years
99 / 368Linearity 3 years
168 / 368Linearity 5 years
33 / 368Linearity 10 years
21 / 368Total Rank
216 / 368Dividend Rank
55 / 368Valuation Rank
18 / 368Piotroski Rank
140 / 368Muliplier Rank
288 / 368Valuation Rank - BEAM ranking 18 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.